NCT00719901 2015-01-12Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 1/2 Terminated11 enrolled 9 charts
NCT00918931 2011-11-04Obatoclax for Systemic MastocytosisM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 2 charts